Literature DB >> 23312875

Improved outcomes with combined autologous chondrocyte implantation and patellofemoral osteotomy versus isolated autologous chondrocyte implantation.

Thai Q Trinh1, Joshua D Harris, Robert A Siston, David C Flanigan.   

Abstract

PURPOSE: To compare clinical outcomes of patients undergoing isolated patellofemoral autologous chondrocyte implantation (ACI) and ACI combined with patellofemoral realignment.
METHODS: A systematic review was performed by use of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines/checklist. We searched PubMed, CINAHL (Cumulative Index to Nursing and Allied Health Literature), SportDiscus, and the Cochrane Central Register of Controlled Trials databases from 1946 through February 2012 to determine whether a difference exists in outcomes of combined ACI and osteotomy versus isolated ACI (minimum 2 years' follow-up). Studies were included only if outcomes were reported separately for both isolated ACI and combined ACI and osteotomy. All ACI generations were eligible for inclusion. Patellofemoral osteotomies eligible for inclusion were anteriorization, medialization, or anteromedialization. All patient-, limb-, and defect-specific characteristics were assessed. All reported clinical scores, radiographic and histologic outcomes, and complications/reoperations were analyzed. Risk of bias was assessed within all studies.
RESULTS: Eleven studies (10 Level III or IV evidence) (366 subjects) were included. Of the defects treated, 78% were located on the patella and 22% on the trochlea. The mean subject age was 33.3 years. Twenty-three percent of subjects underwent concomitant osteotomy. The mean length of follow-up was 4.2 years. Significant (P < .05) improvements in patients undergoing both isolated ACI and combined ACI and osteotomy for patellofemoral chondral defects were observed in all studies. Three studies directly compared isolated ACI and combined ACI and osteotomy, with significantly (P < .05) greater improvements shown in patients undergoing combined osteotomy and ACI (International Knee Documentation Committee subjective score, Lysholm score, Knee Injury and Osteoarthritis Outcome Score, Tegner score, modified Cincinnati score, Short Form 12 score, and Short Form 36 score). There was no significant difference between groups in the rate of postoperative complications overall.
CONCLUSIONS: This review showed statistically significant improvements in patients undergoing both isolated ACI and ACI combined with osteotomy for patellofemoral chondral defects in all studies. When individual studies compared these 2 groups (3 studies), significantly greater improvements in multiple clinical outcomes in subjects undergoing ACI combined with osteotomy were observed. There was no significant difference in the rate of total complications between groups. LEVEL OF EVIDENCE: Level IV, systematic review of studies with minimum Level IV evidence, retrospective case series.
Copyright © 2013 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312875     DOI: 10.1016/j.arthro.2012.10.008

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  23 in total

1.  Unicompartmental arthritis in the aging athlete: osteotomy and beyond.

Authors:  Stephen F Johnstone; Michael J Tranovich; Dharmesh Vyas; Vonda J Wright
Journal:  Curr Rev Musculoskelet Med       Date:  2013-09

2.  Arthroscopic technique for the treatment of patellar chondral lesions with the patient in the supine position.

Authors:  Ricardo Cuéllar; Adrián Cuéllar; Juan Ponte; Miguel A Ruiz-Ibán
Journal:  Arthrosc Tech       Date:  2014-06-02

3.  Matrix-induced autologous chondrocyte implantation (MACI) for chondral defects in the patellofemoral joint.

Authors:  Daniel Meyerkort; Jay R Ebert; Timothy R Ackland; William B Robertson; Michael Fallon; M H Zheng; David J Wood
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-05-11       Impact factor: 4.342

Review 4.  Repair and tissue engineering techniques for articular cartilage.

Authors:  Eleftherios A Makris; Andreas H Gomoll; Konstantinos N Malizos; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Rev Rheumatol       Date:  2014-09-23       Impact factor: 20.543

5.  [Expert consensus on surgical treatment of patellofemoral osteoarthritis].

Authors:  Central South University National Clinical Research Center For Geriatric Disorders Xiangya Hospital
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

6.  Association between patellar cartilage defects and patellofemoral geometry: a matched-pair MRI comparison of patients with and without isolated patellar cartilage defects.

Authors:  Julian Mehl; Matthias J Feucht; Gerrit Bode; David Dovi-Akue; Norbert P Südkamp; Philipp Niemeyer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-30       Impact factor: 4.342

7.  Clinical outcome after medial patellofemoral ligament reconstruction and autologous chondrocyte implantation following recurrent patella dislocation.

Authors:  Rainer Siebold; Georgios Karidakis; Francis Fernandez
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-08-01       Impact factor: 4.342

Review 8.  Early osteoarthritis of the patellofemoral joint.

Authors:  Elizabeth A Arendt; Massimo Berruto; Giuseppe Filardo; Mario Ronga; Stefano Zaffagnini; Jack Farr; Paolo Ferrua; Alberto Grassi; Vincenzo Condello
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-27       Impact factor: 4.342

9.  Clinical outcome and return to work following single-stage combined autologous chondrocyte implantation and high tibial osteotomy.

Authors:  Gerrit Bode; Peter Ogon; Jan Pestka; Jörn Zwingmann; Matthias Feucht; Norbert Südkamp; Philipp Niemeyer
Journal:  Int Orthop       Date:  2014-10-10       Impact factor: 3.075

10.  Significantly worse isokinetic hamstring-quadriceps ratio in patellofemoral compared to condylar defects 4 years after autologous chondrocyte implantation.

Authors:  Sebastian Müller; Anja Hirschmüller; Christoph Erggelet; Nicholas A Beckmann; Peter C Kreuz
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-03       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.